Skip to main content
logo
Stoke Therapeutics, Inc. (FRA:0GT)
Germany flag Germany · Delayed Price · Currency is EUR
24.60
+0.40 (1.65%)
Last updated: Jan 28, 2026, 8:02 AM CET

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022
Period Ending
Dec '23 Dec '22
Antisense Oligonucleotide
8.78M
Antisense Oligonucleotide Growth
-29.22%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022
Period Ending
Dec '23 Dec '22
United States
8.78M
United States Growth
-29.22%